frontotemporal dementia/obesitat

L'enllaç es desa al porta-retalls

Trieu el tipus d'ordenació

12 resultats

Smoking and Obesity as Risk Factors in Frontotemporal Dementia and Alzheimer's Disease: The HUNT Study.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Few studies have assessed smoking and obesity together as risk factors for frontotemporal dementia (FTD) and Alzheimer's disease (AD).To study smoking and obesity as risk factors for FTD and AD.Ninety patients with FTD and 654

Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

People in modern, affluent societies are living longer but also becoming increasingly overweight. With increased life expectancy comes increased risk of developing age-related cognitive decline and neurodegenerative diseases, such that an increasing proportion of life may be lived with cognitive

The neuropathology of obesity: insights from human disease.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Obesity, a pathologic state defined by excess adipose tissue, is a significant public health problem as it affects a large proportion of individuals and is linked with increased risk for numerous chronic diseases. Obesity is the result of fundamental changes associated with modern society including

Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Diabetes and obesity have been implicated as risk factors for dementia. However, metabolic mechanisms and associated signalling pathways have not been investigated in detail in frontotemporal dementia. We therefore here characterised physiological, behavioural and molecular phenotypes of 3- and

Cardiovascular risk factors and frontotemporal dementia: a case-control study.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Cardiovascular risk factors (CRF) were widely described as related to dementia. There are very few studies regarding this association in FTD. The objective of the study was to compare the frequency of CRF in our population with FTD and controls. 100 consecutive subjects with FTD diagnosis according

Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Frontotemporal lobar degeneration (FTLD) is a group of complex neurodegenerative disease characterized by progressive deterioration of the frontal and anterior temporal lobes of the brain resulting in different heterogeneous conditions, mainly characterized by personality changes, behavioral

Progranulin: at the interface of neurodegenerative and metabolic diseases.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Progranulin is a widely expressed, cysteine-rich, secreted glycoprotein originally discovered for its growth factor-like properties. Its subsequent identification as a causative gene for frontotemporal dementia (FTD), a devastating early-onset neurodegenerative disease, has catalyzed a surge of new

Female-Specific Role of Progranulin to Suppress Bone Formation.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Progranulin (PGRN) is best known as a glial protein for which deficiency leads to the most common inherited form of frontotemporal dementia. Recently, PGRN has been found to be an adipokine associated with diet-induced obesity and insulin resistance. Therefore, PGRN may have homeostatic effects on

[Dementia tends to become an impediment to continued homecare - "staying home until death" even with dementia].

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

With the rate of aging rising each year, the number of patients with dementia increases. The latest study released by the Ministry of Health, Labour and Welfare estimated that, as of 2012, there were a total of 3.05 million people with dementia in Japan, with 10% of aged 65 and over, 15% of aged 70

PRECLINICAL MODELS OF DISEASE AND MULTIMORBIDITY WITH FOCUS UPON CARDIOVASCULAR DISEASE AND DEMENTIA

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

The use of animal models is fundamental to furthering our understanding of human disease mechanisms, as well as identifying potential therapeutic targets. Diseases of ageing often involve multiple body systems; however, multi-systemic features are not fully recapitulated in the many of the animal

Body mass index delineates ALS from FTD: implications for metabolic health.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Weight loss and catabolic changes are increasingly recognized as factors that influence outcomes in patients with amyotrophic lateral sclerosis (ALS). An association between disease progression and low BMI has been reported in ALS; however, it remains unknown whether low BMI occurs across all forms

Memantine: a comprehensive review of safety and efficacy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Memantine is an uncompetitive antagonist of the N-methyl-D-aspartate glutamate receptor. It is now approved only for treatment of moderate-to-severe Alzheimer's disease (AD). However, as a growing body of evidence indicates that disturbed glutamate neurotransmission may be central to the

Uneix-te a la nostra
pàgina de Facebook

Herbal & Natural Medicine

La base de dades d’herbes medicinals més completa avalada per la ciència

Funciona en 55 idiomes
Cures a base d'herbes recolzades per la ciència
Reconeixement d’herbes per imatge
Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
Llegiu publicacions científiques relacionades amb la vostra cerca
Cerqueu herbes medicinals pels seus efectes
Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades